Adherium Company Description

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

The company offers Hailie Smartinhaler, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases.

It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.

The company was founded in 2001 and is based in Melbourne, Australia.

Adherium Limited

Country	Australia
Founded	2001
Industry	Medical Devices
Sector	Healthcare
Employees	40
CEO	Paul Mastoridis

Contact Details

Address: 447 Collins Street Melbourne, 3000 Australia
Website	adherium.com

Stock Details

Ticker Symbol	ADR
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000ADR1
SIC Code	3845

Key Executives

Name	Position
Louis James Panaccio BEC, C.A., M.A.I.C.D.	Executive Chairman of the Board
Daniel Kaplon	Chief Financial Officer
Emily Austin	Company Secretary
Nilesh Ghatpande	Vice President of Engineering and Technology
Cassandra Thomas	Vice President of People and Culture
Michael Motion	Consultant
Zoe Park	Head of Software
Nancy She	Head of Supply Chain and Procurement
Michael Gormack	Head of Devices
Dr. John Douglas Wilson ChB, FRACP, FRCPA, MB, Ph.D.	Executive Medical Director